PT  - JOURNAL ARTICLE
AU  - Ali A. Al Haboob
TI  - Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection
AID  - 10.17712/nsj.2021.3.20210002
DP  - 2021 Jul 01
TA  - Neurosciences Journal
PG  - 295--299
VI  - 26
IP  - 3
4099  - http://nsj.org.sa/content/26/3/295.short
4100  - http://nsj.org.sa/content/26/3/295.full
SO  - Neurosciences (Riyadh)2021 Jul 01; 26
AB  - COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache, blurred vision, dysarthria, dysphagia, respiratory failure, muscle weakness, and unsteadiness. He had been exposed to COVID-19 through an asymptomatic elder brother two months prior to his illness. The MRI brain showed findings consistent with PRES and the diagnosis with Miller Fischer variant of the Guillain-Barré syndrome was made. A cerebrospinal fluid analysis revealed cytoalbuminous dissociation, and a nerve conduction velocity study conclusively showed polyneuropathy. A fluoroscopy of the diaphragms found that there was limited movement in both. Although children seem to be less affected by COVID-19 infection, this report highlights on an important neurological complications that can develop in children and its presence should be taken into consideration when diagnosing different forms of Guillain-Barré.